NCT03817606

Brief Summary

The purpose of this study is to compare outcomes of patients with degenerative disc disease undergo lumbar spinal fusion with Stryker's Tritanium® Posterior Lumbar Cage or the UniLIF PEEK implant.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 25, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

March 1, 2019

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2020

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 27, 2021

Completed
8 months until next milestone

Results Posted

Study results publicly available

December 15, 2021

Completed
Last Updated

January 10, 2023

Status Verified

December 1, 2022

Enrollment Period

1.3 years

First QC Date

December 20, 2018

Results QC Date

September 29, 2021

Last Update Submit

December 15, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Fusion Success

    CT and X-ray imaging will be obtained at study visits and Fusion Success will be defined by the following criteria: no lucent area around the implant; no presences of herniated disk, central stenosis, lateral recess stenosis, foraminal stenosis, facet anthropathy; no fracture of the device, graft or vertebra; visible bone formation in or about the graft material; less than 3 degrees of inter-segmental position change on flexion and extension views; presence of subsidence: a migration of more than 3mm into the adjacent vertebra; and the proportion of bridging bone visually estimated over the surface area of the joint

    12 Months

Secondary Outcomes (7)

  • Change in Visual Analogue Scale

    Baseline; 6 weeks; 3 months; 6 months; and 12 months post operation

  • Change in Low Back Function

    Baseline; 6 weeks; 3 months; 6 months; and 12 months post operation

  • Change in Quality of Life: SF-36 PCS

    Baseline; 6 weeks; 3 months; 6 months; and 12 months post operation.

  • Number of Participants That Return to Work

    Baseline; 6 weeks; 3 months; 6 months; and 12 months post operation

  • Ambulatory Status

    Baseline; 6 weeks; 3 months; 6 months; and 12 months post operation

  • +2 more secondary outcomes

Study Arms (2)

Tritanium Posterior Lumbar Cage

EXPERIMENTAL

Surgical placement of the Tritanium Posterior Lumbar Cage

Device: Tritanium Posterior Lumbar Cage

AVS PEEK UniLIF

ACTIVE COMPARATOR

Surgical placement of the AVS PEEK UniLIF Posterior Lumbar Cage

Device: AVS UniLIF PEEK Posterior Lumbar Cage

Interventions

Placement of Tritanium Posterior Lumbar Cage via TLIF procedure

Tritanium Posterior Lumbar Cage

Placement of AVS UniLIF PEEK Posterior Lumbar Cage via TLIF procedure.

AVS PEEK UniLIF

Eligibility Criteria

Age21 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject is skeletally mature
  • Subject has one or more of the following diagnoses:
  • Degenerative Disc Disease (DDD) at one level or two contiguous levels from L2 to S1
  • a. DDD may include up to Grade 1 spondylolisthesis at the involved level(s)
  • Degenerative Scoliosis for which the interbody fusion device will be used as an adjunct to fusion
  • Subject has received 6 months of non-operative therapy
  • Subject understands the conditions of enrollment and is willing to sign and date the Informed Consent
  • Subject agrees to comply with visit schedule and study assessments
  • Provision of signed and dated informed consent form
  • Subject stated willingness to comply with all study procedures and availability for the duration of the study
  • Subject is in good general health as evidenced by medical history

You may not qualify if:

  • Subject is obese (BMI \> 40)
  • Subject is sensitive to titanium materials
  • Subject has an active infection at the operative site
  • Subject has marked local inflammation
  • Subject has any abnormality present which affects the normal process of bone remodeling including, but not limited to, severe osteoporosis involving the spine, bone absorption, osteopenia, tumors involving the spine, active infection at the site, or certain metabolic disorders affecting osteogenesis
  • Subject has any mental, trauma, or neuromuscular disorder which would create an unacceptable risk of fixation failure or complications in postoperative care
  • Subject has any open wounds
  • Subject is pregnant or plans to become pregnant during the course of the study
  • Subject has inadequate tissue coverage over the operative site.
  • Subject has an neuromuscular deficit which places an unsafe load on the device during the healing period
  • Subject has any condition of senility, mental illness, or substance abuse
  • Subject has any other medical or surgical condition which would preclude the potential benefit of spinal implant surgery, such as the presence of tumors, congenital abnormalities, elevation of sedimentation rate unexplained by other diseases, elevation of white blood cell count (WBC), or marked left shift in the WBC differential count.
  • Subject has prior fusion at the levels to be treated
  • Subject is incarcerated

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Riverside Medical Center

Kankakee, Illinois, 60901, United States

Location

MeSH Terms

Conditions

Intervertebral Disc Degeneration

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal Diseases

Results Point of Contact

Title
Cynthia Koehn, Clinical Research Nurse
Organization
Riverside Medical Center

Study Officials

  • Lisa Zipsie

    Riverside Medical Center

    STUDY DIRECTOR
  • Juan Jimenez, MD

    Riverside Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Study participants will not know which posterior lumbar cage they receive.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Parallel randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 20, 2018

First Posted

January 25, 2019

Study Start

March 1, 2019

Primary Completion

June 30, 2020

Study Completion

April 27, 2021

Last Updated

January 10, 2023

Results First Posted

December 15, 2021

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations